OnKure Therapeutics (OKUR) stock: insider trades, news & valuation
Net sellingShare price and insider trades
OnKure Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 2 sold $6K of OKUR stock on the open market.
Get emailed when insiders cluster-buy stocks like OKUR
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
OKUR insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $1K | 2 |
| Q2 2026 | — | 0 | $2K | 2 |
| Q1 2026 | — | 0 | $2K | 2 |
| Q4 2025 | — | 0 | $1K | 2 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 OnKure Therapeutics, Inc. insiders reported open-market purchases totaling $0, while 2 insiders reported sales totaling $6K. 0 of 8 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 23SEC | Jason A. LeveroneCFO | Sell | 30218,500 held (−2%) | $2.97 | $897 | -18.9% | — |
| Sep 23SEC | Nicholas A SaccomanoCEO, President | Sell | 8711,160 held (−1%) | $2.97 | $258 | -18.9% | — |
| Jun 24SEC | Jason A. LeveroneCFO | Sell | 30318,802 held (−2%) | $4.40 | $1K | -45.2% | — |
| Jun 24SEC | Nicholas A SaccomanoCEO, President | Sell | 8611,247 held (−1%) | $4.40 | $378 | -45.2% | — |
| Mar 24SEC | Jason A. LeveroneCFO | Sell | 30116,000 held (−2%) | $4.16 | $1K | -42.1% | — |
| Mar 24SEC | Nicholas A SaccomanoCEO, President | Sell | 867,333 held (−1%) | $4.16 | $358 | -42.1% | — |
| Dec 23SEC | Jason A. LeveroneCFO | Sell | 30216,301 held (−2%) | $2.97 | $897 | -18.9% | — |
| Dec 23SEC | Nicholas A SaccomanoCEO, President | Sell | 877,419 held (−1%) | $2.97 | $258 | -18.9% | — |
Insiders at OnKure Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Jason A. LeveroneCFO | — | $4K | Sep 23, 2026 | — |
| Nicholas A SaccomanoCEO, President | — | $1K | Sep 23, 2026 | — |
OKUR stock: common questions
Are OnKure Therapeutics, Inc. insiders buying OKUR stock?
In the past 12 months, 0 insiders reported open-market purchases of OKUR worth $0.
Are OnKure Therapeutics, Inc. insiders selling OKUR stock?
2 insiders reported sales worth $6K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is OKUR's 52-week range?
Over the past year OKUR has traded between $2.30 and $5.27. It last closed at $2.41 on Oct 9, 2026.